EBSCO Health

EBSCO Health is a leading provider of clinical decision support solutions, healthcare business intelligence, medical journals...
Related Video:

Read the latest evidence about Middle East respiratory syndrome coronavirus (MERS-CoV)

Read about MERS-CoV »

DynaMed provides the evidence-based, unbiased information I need to make decisions. I use DynaMed in real-time during rounds when I need answers to questions that have the potential to change management.
Daniel A. Ostrovsky, MD, Assistant Professor of Medicine and Pediatrics, Duke University

Recent News

DynaMed Plus™ Now Features Micromedex® Evidence-based Content from Truven Health Analytics™

DynaMed Plus users can seamlessly access trusted Micromedex evidence-based content at the point of care including drug dosing, interactions, off-label uses and lab recommendations

Read More »

Introducing eBook Nursing Collection

Designed for use in hospitals, medical institutions, and academic institutions with nursing or allied health programs, this subscription collection features over 300 hand-selected, quality titles that focus on the needs of nursing professionals, including clinical guides, evidence-based practice manuals, practical handbooks, and professional growth titles.

Learn more about eBooks Nursing Collection

See what KLAS has to say

DynaMed rated highest in both Clinical Decision Support 2011: Understanding the Impact and Clinical Decision Support 2013: Sizing up the competition by KLAS, outscoring every competitor—including UpToDate®. Nursing Reference Center rated highest in the nurse reference product category in the 2013 report as well. Read more about KLAS

Make it easy to access all of your library resources from one search box with EDS Discovery Health.

Meet the Clinical Leaders of EBSCO Health

Kevin Loughlin, MD, MBA, MA(Hon)
Deputy Editor, DynaMed

Kevin Loughlin, MD, MBA, MA(Hon) is Deputy Editor of Oncology and Hematology at DynaMed.  He is senior surgeon and a staff urologist at Brigham and Women’s Hospital, Harvard University Health Services, and Dana Farber Cancer Institute.  He is also the director of urologic research at Brigham and Women’s Hospital.  Dr. Loughlin is the program director for the Harvard Longwood Urology Residency Program and a trustee of the American Board of Urology.  He is on multiple journal editorial boards and has substantial research and leadership experience in urologic oncology.  He is board certified from the American Board of Urology.  Dr. Loughlin graduated from New York Medical College, with an MBA from Boston University, and completed his residency at Cornell Medical Center and the Harvard Program in Urology.

Read about our other clinical leaders »